58 related articles for article (PubMed ID: 33443105)
21. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents.
Selvaggi F; Catalano T; Cotellese R; Aceto GM
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454818
[TBL] [Abstract][Full Text] [Related]
22. Drug Discovery of DKK1 Inhibitors.
Jiang H; Zhang Z; Yu Y; Chu HY; Yu S; Yao S; Zhang G; Zhang BT
Front Pharmacol; 2022; 13():847387. PubMed ID: 35355709
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma.
Zhu C; Gu L; Yao M; Li J; Fang C
Front Oncol; 2021; 11():776979. PubMed ID: 34993138
[TBL] [Abstract][Full Text] [Related]
24. Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1).
Gao S; Jin Y; Zhang H
Front Genet; 2021; 12():757897. PubMed ID: 34899842
[TBL] [Abstract][Full Text] [Related]
25. Dickkopf proteins in pathological inflammatory diseases.
Park MH; Shin JH; Bothwell ALM; Chae WJ
J Leukoc Biol; 2022 Apr; 111(4):893-901. PubMed ID: 34890067
[TBL] [Abstract][Full Text] [Related]
26. Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance.
Dholakia J; Scalise CB; Katre AA; Goldsberry WN; Meza-Perez S; Randall TD; Norian LA; Novak L; Arend RC
Gynecol Oncol; 2022 Jan; 164(1):170-180. PubMed ID: 34844776
[TBL] [Abstract][Full Text] [Related]
27. The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs.
Di M; Zhang Y; Zeng R; Liu X; Chen W; Zhang M; Zhang C; Li M; Zhang M
Int J Biol Sci; 2021; 17(15):4122-4139. PubMed ID: 34803487
[No Abstract] [Full Text] [Related]
28. LRPs in WNT Signalling.
Davidson G
Handb Exp Pharmacol; 2021; 269():45-73. PubMed ID: 34490514
[TBL] [Abstract][Full Text] [Related]
29. Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers.
Klempner SJ; Bendell JC; Villaflor VM; Tenner LL; Stein SM; Rottman JB; Naik GS; Sirard CA; Kagey MH; Chaney MF; Strickler JH
Mol Cancer Ther; 2021 Nov; 20(11):2240-2249. PubMed ID: 34482288
[TBL] [Abstract][Full Text] [Related]
30. A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Zhang Y; Chen P; Zhou Q; Wang H; Hua Q; Wang J; Zhong H
Front Genet; 2021; 12():570336. PubMed ID: 34220923
[TBL] [Abstract][Full Text] [Related]
31. Nomogram Incorporating the WNT/β-Catenin Signaling Pathway for Predicting the Survival of Cutaneous Melanoma.
Zhou YX; Wang X; Pang DQ; Wang YM; Bai J; Tian F; Han D; Shi S; Hu L
Int J Gen Med; 2021; 14():2751-2761. PubMed ID: 34188529
[TBL] [Abstract][Full Text] [Related]
32. Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors.
Caldwell C; Rottman JB; Paces W; Bueche E; Reitsma S; Gibb J; Adisetiyo V; Haas MS; Heath H; Newman W; Baum J; Gianani R; Kagey MH
Sci Rep; 2021 May; 11(1):9920. PubMed ID: 33972574
[TBL] [Abstract][Full Text] [Related]
33. The anti-DKK1 antibody DKN-01 as an immunomodulatory combination partner for the treatment of cancer.
Wall JA; Klempner SJ; Arend RC
Expert Opin Investig Drugs; 2020 Jul; 29(7):639-644. PubMed ID: 32408777
[TBL] [Abstract][Full Text] [Related]
34. DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01.
Jarman EJ; Horcas-Lopez M; Waddell SH; MacMaster S; Gournopanos K; Soong DYH; Musialik KI; Tsokkou P; Ng ME; Cambridge WA; Wilson DH; Kagey MH; Newman W; Pollard JW; Boulter L
Liver Int; 2023 Jan; 43(1):208-220. PubMed ID: 35924447
[TBL] [Abstract][Full Text] [Related]
35. DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Arend R; Dholakia J; Castro C; Matulonis U; Hamilton E; Jackson CG; LyBarger K; Goodman HM; Duska LR; Mahdi H; ElNaggar AC; Kagey MH; Liu A; Piper D; Barroilhet LM; Bradley W; Sachdev J; Sirard CA; O'Malley DM; Birrer M
Gynecol Oncol; 2023 May; 172():82-91. PubMed ID: 37001446
[TBL] [Abstract][Full Text] [Related]
36. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.
D'Amico L; Mahajan S; Capietto AH; Yang Z; Zamani A; Ricci B; Bumpass DB; Meyer M; Su X; Wang-Gillam A; Weilbaecher K; Stewart SA; DeNardo DG; Faccio R
J Exp Med; 2016 May; 213(5):827-40. PubMed ID: 27045006
[TBL] [Abstract][Full Text] [Related]
37. Dickkopf-1: A Promising Target for Cancer Immunotherapy.
Chu HY; Chen Z; Wang L; Zhang ZK; Tan X; Liu S; Zhang BT; Lu A; Yu Y; Zhang G
Front Immunol; 2021; 12():658097. PubMed ID: 34093545
[TBL] [Abstract][Full Text] [Related]
38. mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment.
Haas MS; Kagey MH; Heath H; Schuerpf F; Rottman JB; Newman W
Mol Cancer Res; 2021 Apr; 19(4):717-725. PubMed ID: 33443105
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
